Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Balloon Catheters in Cases of Abnormal Placentation (Accreta)

This study has been completed.
Information provided by (Responsible Party):
Raed Salim, HaEmek Medical Center, Israel Identifier:
First received: June 10, 2011
Last updated: June 14, 2015
Last verified: June 2015
Placenta accreta is a relatively rare event, in which the placenta is abnormally implanted into the uterine myometrium. The most significant complication is intense bleeding, mainly during labor. The most important risk factors are previous cesarean delivery, placenta previa, and advanced maternal age. Cesarean hysterectomy is the recommended management. During the recent years, inserting intravascular balloon catheter for occlusion and/or arterial embolization, was introduced as an adjuvant therapy in order to minimize blood loss during cesarean hysterectomy or in conduct with conservative management with the intent of avoiding hysterectomy in selective cases. Contradicting reports exist regarding the effectiveness and safety of the catheters in cases of placenta accreta. The objective of this study is to estimate the efficacy of the balloon catheters among women diagnosed with a placenta accreta.

Condition Intervention
Post Partum Bleeding
Procedure: internal iliac catheterization

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Balloon Catheter for Occlusion of the Pelvic Vasculature as an Adjuvant Therapy in Cases of Placenta Accreta

Resource links provided by NLM:

Further study details as provided by HaEmek Medical Center, Israel:

Primary Outcome Measures:
  • Number of blood products transfused [ Time Frame: 5 years ]

Secondary Outcome Measures:
  • Need for hysterectomy [ Time Frame: 5 years ]
  • catheter`s side effects [ Time Frame: 5 years ]
  • Length of hospitalization [ Time Frame: 5 years ]

Enrollment: 24
Study Start Date: January 2009
Study Completion Date: April 2015
Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: internal iliac catheterization
Women in this arm will undergo internal iliac artery catheterization prior to the cesarean delivery
Procedure: internal iliac catheterization
Women in this arm will undergo internal iliac artery catheterization prior to the cesarean delivery
Other Name: internal iliac artery catheterization
No Intervention: No intervention
no intervention prior to cesarean


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • pregnant women age 18-45
  • antepartum diagnosis of placenta accreta

Exclusion Criteria:

- women who refuse to participate

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01373255

Haemek Medical Center
Afula, Israel
Sponsors and Collaborators
HaEmek Medical Center, Israel
Principal Investigator: Raed Salim Dep. OB/GYN, HaEmek Medical Center, Afula, Israel
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Raed Salim, MD, HaEmek Medical Center, Israel Identifier: NCT01373255     History of Changes
Other Study ID Numbers: 0043-08-EMC
Acreta02 ( Other Identifier: Emek Medical Center )
Study First Received: June 10, 2011
Last Updated: June 14, 2015

Keywords provided by HaEmek Medical Center, Israel:
Placenta accreta
Internal iliac artery catheterization
Post partum bleeding

Additional relevant MeSH terms:
Placenta Accreta
Postpartum Hemorrhage
Pathologic Processes
Obstetric Labor Complications
Pregnancy Complications
Placenta Diseases
Puerperal Disorders
Uterine Hemorrhage processed this record on April 28, 2017